Frank Heinricht, Schott CEO

As a hand­ful of com­pa­nies spin out health busi­ness­es, Ger­many's Schott glass­mak­er looks to get in on the ac­tion

While most peo­ple think of glass as some­thing to drink from or look through, the ma­te­r­i­al al­so has many us­es in phar­ma.

Ger­man glass­mak­er Schott has been man­u­fac­tur­ing glass for a wide range of us­es for 138 years and has built up a ro­bust health­care di­vi­sion.

The com­pa­ny an­nounced on Mon­day that it’s es­tab­lish­ing a stand­alone com­pa­ny specif­i­cal­ly for its phar­ma busi­ness. Ac­cord­ing to Schott, its phar­ma di­vi­sion has grown faster than the mar­ket in re­cent years, war­rant­i­ng a stand­alone com­pa­ny. As part of the carve-out, the phar­ma side will op­er­ate un­der the new name of Schott Phar­ma AG & Co. KGaA. The move is ex­pect­ed to be com­plet­ed by the end of the year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.